Speakers

Tobias Brandt

Senior Scientist, Viral Vector Process Development • CSL Behring

Tobias Brandt is leading the lentiviral vector downstream process development team at CSL Behring. After joining CSL’s recombinant protein team in 2016, Tobias started to build up the lentiviral process development labs at CSL’s Marburg site. Besides process development, Tobias is responsible for downstream scale-up and process transfer to manufacturing sites as well as biosafety.

Tobias acquired his PhD in Biological Sciences from the University of Cambridge, UK, and the MRC Laboratory of Molecular Biology and holds a diploma in Chemistry from the University of Marburg, Germany. Before joining CSL, Tobias worked as a post-doctoral researcher at the Max-Planck Institute for Biophysics, Frankfurt, Germany, concentrating on structural biology research of mitochondria using cryo-electron microscopy.

 

Also speaking

Jack Reid

Co-Founder • Unicorn Biotechnologies

John Garcia

PhD, Head of New Manufacturing Technologies • UCL

Becky Johnson-Kent

DIRECTOR OF COMMERCIAL PARTNERSHIPS AND HEAD OF WOMEN IN ADVANCED THERAPIES • Phacilitate

Event Info

Image

Sample Attendee List – 2024

Download and explore the 2024 Floorplan for Advanced Therapies Europe here.
Image

Enquire to Sponsor/Exhibit

Take a look at the sample attendee list for Advanced Therapies Europe 2024 here.